Physician

Anita Tharian, DO

According to 2025 Medicare claims, Anita Tharian, DO (NPI: 1457367112) practices hematology/oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Dallas, TX. This provider's primary affiliated billing organization is UROLOGY CLINICS OF NORTH TEXAS, PLLC (NPI: 1720031370; TIN: 752788839) and primary practice location at 75243-1915. Tharian is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Tharian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 972 traditional Medicare patients, billed 117,811 HCPCS/CPT codes, and received $4,936,201 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 1,388 prescription claims across 270 beneficiaries totaling $3,080,446 in drug costs, led by Xtandi (Enzalutamide). 2020 DME data shows 28 claims. Open Payments data shows 42 records totaling $950. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $47,624 to $4,936,201. Similarly, Part D prescription costs have risen steadily, from $385,043 to $3,080,446. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	225	591	$47,624
2016	204	458	$37,198
2017	212	534	$41,596
2018	172	453	$35,895
2019	442	21,995	$302,337
2020	523	73,547	$1,360,369
2021	594	51,996	$1,258,767
2022	610	67,065	$1,220,101
2023	598	122,453	$2,513,771
2024	972	117,811	$4,936,201

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	157	861	$385,043
2016	148	835	$734,326
2017	183	1,192	$1,841,012
2018	171	1,080	$1,551,684
2019	179	1,171	$1,561,171
2020	189	1,103	$1,664,362
2021	204	1,218	$2,079,115
2022	238	1,420	$2,362,669
2023	266	1,587	$2,444,498
2024	270	1,388	$3,080,446

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$2,907
2016	N/R	61	$15,813
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	28	$2,267
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	449	480	$1,156
A9595	Piflufolastat f-18, diagnostic, 1 millicurie	234	2,084	$459
77067	Screening mammography	250	250	$112
77063	Screening 3d breast mammography	250	250	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	166	370	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	54	1,620	$759,482
Sprycel	Dasatinib	13	570	$354,928
Imbruvica	Ibrutinib	21	588	$327,390
Verzenio	Abemaciclib	21	588	$321,062
Inlyta	Axitinib	13	390	$236,218

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$950	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anita Tharian, DO?

Tedicare shows public-source Medicare data for Anita Tharian, DO (NPI 1457367112), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anita Tharian, DO have ACO affiliation data?

Anita Tharian, DO is shown with ACO affiliation data for UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Anita Tharian, DO?

Anita Tharian, DO is linked to UROLOGY CLINICS OF NORTH TEXAS, PLLC (billing NPI 1720031370) in the available physician profile data.

Does Anita Tharian, DO have Open Payments data?

Anita Tharian, DO has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.